The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice
Abstract
Method: We injected two drugs that modify the epigenome, the DNA methyltransferase inhibitor 5-aza-2´-deoxycytidine (5-aza-dC) and the histone deacetylase inhibitor trichostatin A (TSA), alone or in combination, into C57Bl/6 mice subjected to amputation through the mid-second phalanx of the third digit. Wound-site tissue was collected. Results: We observed increased staining of the stem cell markers Rex1 (Zfp42) and stem cell antigen-1 at digit amputation sites from drug-treated mice. Samples from 5-aza-dC plus TSA and TSA treated mice also showed increased proliferating cell nuclear antigen staining, a measure of cell proliferation. Drug treatments increased Msx1, but not Cyp26a1 or ALDH1a2 (RALDH2) mRNA. Conclusion: 5-aza-dC and TSA treatments stimulated cell proliferation at the amputation site, possibly via increased expression of genes involved in digit development and regeneration.
Bibliography
- 1 Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, Muneoka K: Limb regeneration in higher vertebrates: developing a roadmap. Anat. Rec. B New Anat.287(1),14–24 (2005).
- 2 Kragl M, Knapp D, Nacu E et al.: Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature460(7251),60–65 (2009).
- 3 Yokoyama H, Ogino H, Stoick-Cooper CL, Grainger RM, Moon RT: Wnt/β-catenin signaling has an essential role in the initiation of limb regeneration. Dev. Biol.306(1),170–178 (2007).
- 4 Stocum DL: Regenerative biology and engineering: strategies for tissue restoration. Wound Repair Regen.6(4),276–290 (1998).
- 5 Bryant SV, Endo T, Gardiner DM: Vertebrate limb regeneration and the origin of limb stem cells. Int. J. Dev. Biol.46(7),887–896 (2002).
- 6 Brockes JP, Kumar A: Appendage regeneration in adult vertebrates and implications for regenerative medicine. Science310(5756),1919–1923 (2005).
- 7 Borgens RB: Mice regrow the tips of their foretoes. Science217(4561),747–750 (1982).
- 8 Illingworth CM: Trapped fingers and amputated finger tips in children. J. Pediatr. Surg.9(6),853–858 (1974).
- 9 Neufeld DA, Zhao W: Bone regrowth after digit tip amputation in mice is equivalent in adults and neonates. Wound Repair Regen.3(4),461–466 (1995).
- 10 Reginelli AD, Wang YQ, Sassoon D, Muneoka K: Digit tip regeneration correlates with regions of msx1 (hox 7) expression in fetal and newborn mice. Development121(4),1065–1076 (1995).
- 11 Han M, Yang X, Lee J, Allan CH, Muneoka K: Development and regeneration of the neonatal digit tip in mice. Dev. Biol.315(1),125–135 (2008).
- 12 Mohammad KS, Day FA, Neufeld DA: Bone growth is induced by nail transplantation in amputated proximal phalanges. Calcif. Tissue Int.65(5),408–410 (1999).
- 13 Allan CH, Fleckman P, Fernandes RJ et al.: Tissue response and msx1 expression after human fetal digit tip amputation in vitro. Wound Repair Regen.14(4),398–404 (2006).
- 14 Han M, Yang X, Farrington JE, Muneoka K: Digit regeneration is regulated by msx1 and BMP4 in fetal mice. Development130(21),5123–5132 (2003).
- 15 Masaki H, Ide H: Regeneration potency of mouse limbs. Dev. Growth Differ.49(2),89–98 (2007).
- 16 Chadwick RB, Bu L, Yu H et al.: Digit tip regrowth and differential gene expression in MRL/Mpj, DBA/2, and C57BL/6 mice. Wound Repair Regen.15(2),275–284 (2007).
- 17 Yakushiji N, Suzuki M, Satoh A et al.: Correlation between shh expression and DNA methylation status of the limb-specific shh enhancer region during limb regeneration in amphibians. Dev. Biol.312(1),171–182 (2007).
- 18 Yakushiji N, Yokoyama H, Tamura K: Repatterning in amphibian limb regeneration: a model for study of genetic and epigenetic control of organ regeneration. Semin. Cell Dev. Biol.20(5),565–574 (2009).
- 19 Vigushin DM, Ali S, Pace PE et al.: Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res.7(4),971–976 (2001).
- 20 Liu T, Kuljaca S, Tee A, Marshall GM: Histone deacetylase inhibitors: multifunctional anticancer agents. Cancer Treat. Rev.32(3),157–165 (2006).
- 21 Schroeder TM, Westendorf JJ: Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res.20(12),2254–2263 (2005).
- 22 De Boer J, Licht R, Bongers M, Van Der Klundert T, Arends R, Van Blitterswijk C: Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng.12(10),2927–2937 (2006).
- 23 Yildirim F, Gertz K, Kronenberg G et al.: Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp. Neurol.210(2),531–542 (2008).
- 24 Bar-Sela G, Jacobs KM, Gius D: Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells. Cancer J.13(1),65–69 (2007).
- 25 Mongan NP, Gudas LJ: Valproic acid, in combination with all-trans retinoic acid and 5-aza-2´-deoxycytidine, restores expression of silenced RARβ2 in breast cancer cells. Mol. Cancer Ther.4(3),477–486 (2005).
- 26 Marquez VE, Kelley JA, Agbaria R et al.: Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Ann. NY Acad. Sci.1058,246–254 (2005).
- 27 Gal-Yam EN, Saito Y, Egger G, Jones PA: Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med.59,267–280 (2008).
- 28 Ghoshal K, Bai S: DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc)43(6),395–422 (2007).
- 29 Horswill MA, Narayan M, Warejcka DJ, Cirillo LA, Twining SS: Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. Exp. Eye Res.86(4),586–600 (2008).
- 30 Gore SD, Baylin S, Sugar E et al.: Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res.66(12),6361–6369 (2006).
- 31 Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B et al.: Phase 1/2 study of the combination of 5-aza-2´-deoxycytidine with valproic acid in patients with leukemia. Blood108(10),3271–3279 (2006).
- 32 Hurtubise A, Momparler RL: Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-aza-2´-deoxycytidine (decitabine) on human breast carcinoma cells. Cancer Chemother. Pharmacol.58(5),618–625 (2006).
- 33 Huangfu D, Maehr R, Guo W et al.: Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol.26(7),795–797 (2008).
- 34 Montanaro F, Liadaki K, Volinski J, Flint A, Kunkel LM: Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc. Natl Acad. Sci. USA100(16),9336–9341 (2003).
- 35 Asakura A: Stem cells in adult skeletal muscle. Trends Cardiovasc. Med.13(3),123–128 (2003).
- 36 Hosler BA, Larosa GJ, Grippo JF, Gudas LJ: Expression of rex-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell Biol.9(12),5623–5629 (1989).
- 37 Mongan NP, Martin KM, Gudas LJ: The putative human stem cell marker, rex-1 (ZFP42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol. Carcinog.45(12),887–900 (2006).
- 38 Mongan NP, Gudas LJ: Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation75(9),853–870 (2007).
- 39 Scotland KB, Chen S, Sylvester R, Gudas LJ: Analysis of rex1 (ZFP42) function in embryonic stem cell differentiation. Dev. Dyn.238(8),1863–1877 (2009).
- 40 Mccabe MT, Low JA, Daignault S, Imperiale MJ, Wojno KJ, Day ML: Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res.66(1),385–392 (2006).
- 41 Tang XH, Vivero M, Gudas LJ: Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp. Cell. Res.314(1),38–51 (2008).
- 42 Gillespie RF, Gudas LJ: Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARb(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol.372(2),298–316 (2007).
- 43 Holte H, Suo Z, Smeland EB, Kvaloy S, Langholm R, Stokke T: Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers. Acta Oncol.38(4),495–503 (1999).
- 44 Rogers MB, Hosler BA, Gudas LJ: Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development113(3),815–824 (1991).
- 45 Hosler BA, Rogers MB, Kozak CA, Gudas LJ: An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene rex-1 (ZFP-42) in F9 teratocarcinoma cells. Mol. Cell. Biol.13(5),2919–2928 (1993).
- 46 Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J: Stem cells. Setting standards for human embryonic stem cells. Science300(5621),913–916 (2003).
- 47 Kashyap V, Rezende NC, Scotland KB et al.: Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the nanog, OCT4 and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell micro-RNAs. Stem Cells Devel.18(7),1093–1108 (2009).
- 48 Short B, Brouard N, Driessen R, Simmons PJ: Prospective isolation of stromal progenitor cells from mouse BM. Cytotherapy3(5),407–408 (2001).
- 49 Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ: Mesenchymal stem cells. Arch. Med. Res.34(6),565–571 (2003).
- 50 Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA: Sca-1(POS) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol.245(1),42–56 (2002).
- 51 Xin L, Lawson DA, Witte ON: The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl Acad. Sci. USA102(19),6942–6947 (2005).
- 52 Burger PE, Xiong X, Coetzee S et al.: Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc. Natl Acad. Sci. USA102(20),7180–7185 (2005).
- 53 Toma JG, Akhavan M, Fernandes KJ et al.: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol.3(9),778–784 (2001).
- 54 Fernandes KJ, Mckenzie IA, Mill P et al.: A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol.6(11),1082–1093 (2004).
- 55 Oh H, Bradfute SB, Gallardo TD et al.: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA100(21),12313–12318 (2003).
- 56 Matsuura K, Nagai T, Nishigaki N et al.: Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem.279(12),11384–11391 (2004).
- 57 Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW: Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology37(3),632–640 (2003).
- 58 Langton S, Gudas LJ: Cyp26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev. Biol.315(2),331–354 (2008).
- 59 Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M: Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem. J.392(Pt 1),241–248 (2005).
- 60 Maden M, Hind M: Retinoic acid, a regeneration-inducing molecule. Dev. Dyn.226(2),237–244 (2003).
- 61 Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, Dolle P: Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat. Genet.31(1),84–88 (2002).
- 62 Yashiro K, Zhao X, Uehara M et al.: Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev. Cell6(3),411–422 (2004).
- 63 Zhao R, Daley GQ: From fibroblasts to IPS cells: induced pluripotency by defined factors. J. Cell. Biochem.105(4),949–955 (2008).
- 64 Sandell LL, Sanderson BW, Moiseyev G et al.: RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development. Genes Dev.21(9),1113–1124 (2007).
- 65 Neufeld DA: Partial blastema formation after amputation in adult mice. J. Exp. Zool.212(1),31–36 (1980).
- 66 Revardel JL, Chebouki F: Etude de la reponse a l’amputation des phalanges chez la souris: role morphogenetique des epitheliums, stimulation de la chondrogenese. Can. J. Zool.65,3166–3176 (1987).
- 67 Yokoyama H: Initiation of limb regeneration: the critical steps for regenerative capacity. Dev. Growth Differ.50(1),13–22 (2008).
- 68 Gardiner DM, Endo T, Bryant SV: The molecular basis of amphibian limb regeneration: integrating the old with the new. Semin. Cell Dev. Biol.13(5),345–352 (2002).
- 69 Brockes JP, Kumar A: Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat. Rev. Mol. Cell. Biol.3(8),566–574 (2002).
- 70 Nakatani Y, Nishidate M, Fujita M, Kawakami A, Kudo A: Migration of mesenchymal cell fated to blastema is necessary for fish fin regeneration. Dev. Growth Differ.50(2),71–83 (2008).
- 71 Broughton G 2nd, Janis JE, Attinger CE: The basic science of wound healing. Plast. Reconstr. Surg.117(7 Suppl.),12S–34S (2006).
- 72 Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature453(7193),314–321 (2008).
- 73 Bruder SP, Fink DJ, Caplan AI: Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell. Biochem.56(3),283–294 (1994).
- 74 Jiang Y, Jahagirdar BN, Reinhardt RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature418(6893),41–49 (2002).
- 75 Zuk PA, Zhu M, Mizuno H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng.7(2),211–228 (2001).
- 76 Tamaki T, Akatsuka A, Ando K et al.: Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell. Biol.157(4),571–577 (2002).
- 77 Stocum DL: Stem cells in regenerative biology and medicine. Wound Repair Regen.9(6),429–442 (2001).
- 78 Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH: Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl Acad. Sci. USA101(47),16659–16664 (2004).
- 79 Kramer OH, Gottlicher M, Heinzel T: Histone deacetylase as a therapeutic target. Trends Endocrinol. Metab.12(7),294–300 (2001).
- 80 Holmes C, Stanford WL: Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells25(6),1339–1347 (2007).
- 81 Kafadar KA, Yi L, Ahmad Y, So L, Rossi F, Pavlath GK: Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration. Dev. Biol.326(1),47–59 (2009).
- 82 Simon HG, Nelson C, Goff D, Laufer E, Morgan BA, Tabin C: Differential expression of myogenic regulatory genes and Msx-1 during dedifferentiation and redifferentiation of regenerating amphibian limbs. Dev. Dyn.202(1),1–12 (1995).
- 83 Odelberg SJ, Kollhoff A, Keating MT: Dedifferentiation of mammalian myotubes induced by Msx1. Cell103(7),1099–1109 (2000).
- 84 White JA, Beckett-Jones B, Guo YD et al.: cDNA cloning of human retinoic acid-metabolizing enzyme (HP450RAI) identifies a novel family of cytochromes p450. J. Biol. Chem.272(30),18538–18541 (1997).
- 85 Yokouchi Y, Ohsugi K, Sasaki H, Kuroiwa A: Chicken homeobox gene Msx-1: Structure, expression in limb buds and effect of retinoic acid. Development113(2),431–444 (1991).
- 86 Wang Y, Sassoon D: Ectoderm–mesenchyme and mesenchyme–mesenchyme interactions regulate Msx-1 expression and cellular differentiation in the murine limb bud. Dev. Biol.168(2),374–382 (1995).
- 87 Lateef H, Abatan OI, Aslam MN, Stevens MJ, Varani J: Topical pretreatment of diabetic rats with all-trans retinoic acid improves healing of subsequently induced abrasion wounds. Diabetes54(3),855–861 (2005).
- 101 National Centre for Biotechnology Information, Gene Expression Omnibus www.ncbi.nlm.nih.gov/projects/geo/